Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC - Concepedia

Concepedia

Publication | Open Access

Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC

DOI Full Paper Access

106

Citations

14

References

2017

Year

Jennifer J. Knox, Carlos H. Barrios, T.M. Kim, Thomas M. Cosgriff, Vichien Srimuninnimit, K. Pittman, Roberto Sabbatini, Sun Young Rha, Thomas W. Flaig, Ray D. Page,

Annals of Oncology

References

	Year	Citations

Page 1